Figure 2.
Regulation of survivin expression by imatinib at both RNA and protein levels in Ph+ KBM5 cells. (A) Survivin RNA levels in KBM5 cells treated with 1 μM imatinib determined by TaqMan RT-PCR at 24 and 48 hours. (B) Survivin protein levels at 24 hours in KBM5 cells treated with 1 μM imatinib in the presence or absence of proteasome inhibitor MG132.